POSTPONED - China/EU Pharmaceutical Industry Forum Wavre, Belgium

** Event postponed until Autumn 2020 **

The workshop covers 4 different themes, namely Pharmaceuticals in the Environment, ICH Q12 Product Life Cycle Management, Harmonisation of Chinese and European Pharmacopoeias and Pricing & Reimbursement, including HTA.

We have already got confirmation from a setup of experienced EFPIA, EMA, Commission and EDQM speakers, who are presented below.

  • Marilena-Silvia Lungu from the EU Commission, DG Santé will present on EU Strategic Approach to Pharmaceuticals in the Environment (PIE).
  • The Director of EDQM Susanne Keitel will present on Opportunities and challenges re harmonisation of European and Chinese Pharmacopoeias.
  • Paulo Tozzi, member of EFPIA Pharmacopoeia group, will present on Harmonisation of Chinese and European pharmacopoeia - wishes from EFPIA.
  • Bengt Mattson, co-chair of the EFPIA Pharmaceutical in the Environment (PIE-TF) will present on Eco-Pharmaco - Stewardship - A Holistic Approach to PIE.
  • Edit Frénoy, Director Market Access at EFPIA will present on Health Technology Assessments in Europe.
  • Pär Tellner, Team Leader, Regulatory, Drug Development and Manufacturing at EFPIA will moderate the afternoon session and the panel discussion.
  • Jean-Louis Robert, EU/EMA Topic Lead ICH Q12 will present on Implementation of ICH Q12 in Europe.
  • Graham Cook, EFPIA Topic Lead ICH Q12 will present on Overview and benefits of ICH Q12 guideline.

This workshop is jointly organised by